Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hemorrhage × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 15 Genitourinary 8 Other hematologic neoplasm 5 Classical hematology 3 CNS 3 Thoracic 2 Lymphoid 2 Sarcoma 1 Plasma cell 1 Gynecologic 1 Endocrine 1

Conditions

Sarcoma 1107 Glioblastoma 431 Gliosarcoma 413 Osteosarcoma 307 Brain Neoplasms 279 Central Nervous System Neoplasms 249 Astrocytoma 230 Dendritic Cell Sarcoma, Interdigitating 222 Gastrointestinal Stromal Tumors 215 Glioma 197 Neoplasms 195 Lymphoma 194 Neuroblastoma 186 Rhabdomyosarcoma 179 Sarcoma, Ewing 176 Breast Neoplasms 175 Lymphoma, Non-Hodgkin 173 Burkitt Lymphoma 171 Recurrence 169 Oligodendroglioma 169 Precursor Cell Lymphoblastic Leukemia-Lymphoma 168 Lymphoma, Large B-Cell, Diffuse 150 Melanoma 149 Bone Neoplasms 145 Neoplasm Metastasis 144 Ovarian Neoplasms 143 Lymphoma, Follicular 135 Lymphoma, Mantle-Cell 123 Leukemia, Lymphocytic, Chronic, B-Cell 123 Hodgkin Disease 121

Interventions

Tranexamic Acid 1 Fibrin Tissue Adhesive 1 Diathermy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02153593 2016-09-20

TRANEXTUM

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 3 Terminated

Bone Neoplasms, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡